Bruce S. Morra

Bruce S. Morra has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Unigene Laboratories Inc and SCOLR Pharma, Inc. Over a trading history stretching from 6 January 2009 to 6 July 2010, the count stands at 7 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 8 July 2010 came the latest disclosure, a share grant for €7,124 in Unigene Laboratories Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.